Nov 6 (Reuters) - AstraZeneca PLC AZN.L
* AstraZeneca Canada says Health Canada has approved Imfinzi for treatment of advanced bladder cancer in previously treated patients
* AstraZeneca Canada says Imfinzi has been granted notice of compliance with conditions (noc/c) based on tumour response rate and durability of response